Evidence map›Paper›PMID 33306025›Full record

ArticleeLife2020

Salivary and plasmatic oxytocin are not reliable trait markers of the physiology of the oxytocin system in humans.

Daniel Martins, Anthony S Gabay, Mitul Mehta, Yannis Paloyelis

Open access · goldAbstract readComparative Study
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder.Autism research : official journal of the International Society for Autism Research · 2023
    Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Navigating Central Oxytocin Transport: Known Realms and Uncharted Territories.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2025
    Review
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Daniel MartinsDepartment of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, United Kingdom.ORCID 0000-0002-0239-8206
Anthony S GabayDepartment of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, United Kingdom.ORCID 0000-0002-6946-1046
Mitul MehtaDepartment of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, United Kingdom.
Yannis PaloyelisDepartment of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, United Kingdom.ORCID 0000-0002-4029-3720
King's College London · GB

Funding

Economic and Social Research Council ES/K009400/1
6 · The paper itself

Abstract

Single measurements of salivary and plasmatic oxytocin are used as indicators of the physiology of the oxytocin system. However, questions remain about whether they are sufficiently stable to provide valid trait markers of the physiology of the oxytocin system, and whether salivary oxytocin can accurately index its plasmatic concentrations. Using radioimmunoassay, we measured baseline plasmatic and/or salivary oxytocin from two independent datasets. We also administered exogenous oxytocin intravenously and intranasally in a triple dummy, within-subject, placebo-controlled design and compared baseline levels and the effects of routes of administration. Our findings question the use of single measurements of baseline oxytocin concentrations in saliva and plasma as valid trait markers of the physiology of the oxytocin system in humans. Salivary oxytocin is a weak surrogate for plasmatic oxytocin. The increases in salivary oxytocin observed after intranasal oxytocin most likely reflect unabsorbed peptide and should not be used to predict treatment effects.

Indexed as

Diagnostic Techniques, EndocrineAdministration, IntranasalAdministration, IntravenousAdolescentAdultBiomarkersEndocrine SystemHumansMaleOxytocinPredictive Value of TestsRadioimmunoassayReproducibility of ResultsSalivaTime FactorsYoung AdultBiomarkersOxytocinbiomarkerhumanneuroscienceoxytocinplasmaradioimmunoassaysaliva

Identifiers

PMID33306025
PMCPMC7732341
OpenAlexW3112368366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.